"\nText\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n|\n\n\n\n52013PC0222\n\nProposal for a COUNCIL DECISION on the position to be adopted, on behalf of the European Union, in the Joint Committee established by the Agreement between the European Community and the Principality of Monaco on the application of certain Community Acts on the territory of the Principality of Monaco /* COM/2013/0222 final - 2013/0116 (NLE) */\n\n\n\n\n\n\n\n\n\nEXPLANATORY MEMORANDUM\n1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONTEXT OF THE PROPOSAL\nThe Agreement between the European\nCommunity and the Principality of Monaco on the application of certain\nCommunity Acts on the territory of the Principality of Monaco of 4 December\n2003[1] facilitates economic activities\nand trade in medicines for human and veterinary use, cosmetic products and\nmedical devices between the Parties to the Agreement. \nThe Agreement provides in its Article 1,\nparagraph 1, that the Joint Committee established by the Agreement shall amend\nits Annex to ensure that European Union Acts falling within the scope of the\nAgreement apply on the territory of Monaco. \nThe Annex to the Agreement has never been updated\nsince its entry into force in 2004. Since then, the European Union has adopted\na number of acts that fall within the scope of the Agreement and some acts appearing\nin the Annex have been repealed. \nThe present proposal therefore aims to\nupdate the Annex to include the new acts and to remove the acts that have been\nrepealed. In order to establish the position to be taken on behalf of the Union\nin the Joint Committee, a Council Decision is necessary.\n2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LEGAL ELEMENTS OF THE\nPROPOSAL\nSummary of the proposed action\nThis is a proposal for a Council Decision\non the position to be taken on behalf of the Union within the Joint Committee\nestablished by the Agreement, which should be based on the draft Joint\nCommittee Decision in annex.\nLegal basis\nArticle 207 of the Treaty on the\nFunctioning of the European Union in conjunction with Article 218(9) thereof.\nChoice of instrument\nArticle 218(9) of the Treaty on the\nFunctioning of the European Union provides that a Council Decision establishes\nthe position to be adopted on behalf of the European Union in a body set up by\nan agreement, when that body is called upon to adopt decisions having legal\neffects.\nProportionality\nThe proposal is in line with the principle\nof proportionality because its effects are strictly limited to what is\nnecessary to update the Annex to the Agreement to reflect the state of EU\nlegislation in the areas falling within its scope.\n2013/0116 (NLE)\nProposal for a\nCOUNCIL DECISION\non the position to be adopted, on behalf\nof the European Union, in the Joint Committee established by the Agreement\nbetween the European Community and the Principality of Monaco on the\napplication of certain Community Acts on the territory of the Principality of\nMonaco\nTHE COUNCIL OF THE EUROPEAN UNION,\nHaving regard to the Treaty on the\nFunctioning of the European Union, and in particular Article 207 in conjunction\nwith Article 218(9) thereof, \nHaving regard to the proposal from the\nEuropean Commission,\nWhereas: \n(1)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The Agreement between the\nEuropean Community and the Principality of Monaco on the application of certain\nCommunity Acts on the territory of the Principality of Monaco of 4 December\n2003[2] entered into force on 1 May\n2004,\n(2)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The Agreement provides in\nits article 1, paragraph 1, that the Joint Committee established by the\nAgreement shall amend its Annex to ensure that Union Acts falling within the\nscope of the Agreement apply on the territory of Monaco,\n(3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Since the entry into force\nof the Agreement, the European Union has adopted a number of acts that fall\nwithin its scope and some acts appearing in the Annex have been repealed. It is\ntherefore necessary to update the Annex to include the new acts and to remove the\nacts that have been repealed,\n(4)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Council Decision\n2003/885/EC of 17 November 2003 on the conclusion of the Agreement on the application\nof certain Community Acts on the territory of the Principality of Monaco,\nnotably its article 3, paragraph 1, provides that the European Union shall be\nrepresented by the Commission on the Joint Committee,\n(5)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Council Decision\n2003/885/EC of 17 November 2003, notably its article 3, paragraph 2, provides\nthat the position to be taken by the European Union in the Joint Committee\nshall be determined by the Council on a proposal from the Commission; the\nCouncil shall act by the same voting rule as that applicable for the adoption\nof the Union act concerned,\nHAS ADOPTED THIS DECISION: \nArticle 1\nThe position to be taken by the European\nUnion within the Joint Committee set up by the Agreement between the European\nCommunity and the Principality of Monaco on the application of certain\nCommunity Acts on the territory of the Principality of Monaco of 4 December\n2003 shall be based on the draft decision of the Joint Committee attached to\nthis Decision.\nMinor changes to the draft Decision may be\nagreed to by the representatives of the Union in the Joint Committee without\nfurther decision of the Council.\nArticle 2\nThe Decision of the Joint Committee shall\nbe published in the Official Journal of the European Union.\nArticle 3\nThis Decision shall enter into force on the\nday of its adoption.\nThis Decision\nis addressed to the Commission in accordance with the Treaties.\nDone at Brussels, \n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 For\nthe Council\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The\nPresident \nDraft\nDECISION\nNo. \u2026 OF THE EU-MONACO JOINT COMMITTEE\nof\u2026\nAmending\nthe Annex to the Agreement\nTHE JOINT COMMITTEE,\nHaving regard to the Agreement between the\nEuropean Community and the Principality of Monaco on the application of certain\nCommunity Acts on the territory of the Principality of Monaco of 4 December\n2003[3], and in particular Article 1,\nparagraph 1 thereof,\nWhereas:\n(1)                   \nThe Agreement between the European Community and\nthe Principality of Monaco on the application of certain Community Acts on the\nterritory of the Principality of Monaco of 4 December 2003[4] entered into force on 1 May\n2004,\n(2)                   \nThe Agreement provides in its Article 1,\nparagraph 1, that the Joint Committee established by the Agreement shall amend\nits Annex to ensure that European Union acts falling within the scope of the\nAgreement apply on the territory of Monaco,\n(3)                   \nSince the entry into force of the Agreement, the\nEuropean Union has adopted a number of acts that fall within its scope and some\nacts appearing in the Annex have been repealed. A Decision of the Joint\nCommittee is therefore necessary to update the Annex to include the new acts\nand to remove the acts that have been repealed,\n(4)                   \nIt is recalled that acts of the European\nCommission adopted in application of the acts listed in the Annex to the\nAgreement are applicable on the territory of Monaco without the need for a\nJoint Committee Decision, as provided for by Article 1, paragraph 2, of the\nAgreement,\nHAS ADOPTED THIS DECISION:\nArticle 1\nThe Annex to the Agreement between the\nEuropean Community and the Principality of Monaco on the application of certain\nCommunity Acts on the territory of the Principality of Monaco of 4 December\n2003 is hereby replaced by the Annex to this Decision.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \n\nArticle 2\nThis Decision shall enter into force on the\nday of its adoption. \nDate: \n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 By\nthe Joint Committee\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The\nChairman \n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \nANNEX \nTo\nDecision No. \u2026 of the Committee established by the Agreement between the\nEuropean Community and the Principality of Monaco on the application of certain\nCommunity acts on the territory of the Principality of Monaco of 4 December\n2003\nI. MEDICINAL PRODUCTS\nACTS REFERRED TO\n1.     \nDirective 2001/83/EC of the European Parliament\nand of the Council of 6 November 2001 on the Community code relating to\nmedicinal products for human use\n\u2013     \nAmended by Directive 2012/26/EU of the European\nParliament and of the Council of 25 October 2012 as regards pharmacovigilance\n(OJ L 299, 27.10.2012, p. 1\u20134)\n\u2013     \nAmended by Directive 2011/62/EU of the European\nParliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on\nthe Community code relating to medicinal products for human use, as regards the\nprevention of the entry into the legal supply chain of falsified medicinal\nproducts(Official Journal L174, 1.7.2011, p. 74-87)\n\u2013     \nAmended by Directive 2010/84/EU of the European\nParliament and of the Council of 15 December 2010 amending, as regards\npharmacovigilance, Directive 2001/83/EC on the Community code relating to\nmedicinal products for human use. (Official Journal L 348, 31.12.2010, p. 74 - 99).\n\u2013     \nAmended by Commission Directive 2009/120/EC of\n14 September 2009 amending Directive 2001/83/EC of the European Parliament and\nof the Council on the Community code relating to medicinal products for human\nuse as regards advanced therapy medicinal products (Official Journal L 242\n15.9.2009, p. 3 - 12) .\n\u2013     \nAmended by Directive 2009/53/EC of the European\nParliament and of the Council of 18 June 2009 amending Directive 2001/82/EC and\nDirective 2001/83/EC, as regards variations to the terms of marketing\nauthorisations for medicinal products. (Official Journal L 168, 30.6.2009, p.\n33 - 34).\n\u2013     \nAmended by Directive 2008/29/EC of the European\nParliament and of the Council of 11 March 2008 amending Directive 2001/83/EC on\nthe Community code relating to medicinal products for human use, as regards the\nimplementing powers conferred on the Commission (Official Journal L 81,\n20.3.2008, p. 51 - 52 ).\n\u2013     \nAmended by Regulation (EC) No 1394/2007 of the\nEuropean Parliament and of the Council of 13 November 2007 on advanced therapy\nmedicinal products and amending Directive 2001/83/EC and Regulation (EC) No\n726/2004 (Official Journal L 324, 10.12.2007, p. 121-137)\n\u2013     \nAmended by Regulation (EC) No 1901/2006 of the\nEuropean Parliament and of the Council of 12 December 2006 on medicinal\nproducts for paediatric use and amending Regulation (EEC) No 1768/92, Directive\n2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Official\nJournal L 378, 27.12.2006, p. 1-19).\n\u2013     \nAmended by Directive 2004/27/EC of the European\nParliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on\nthe Community code relating to medicinal products for human use (Official\nJournal L 136, 30.4.2004, p. 34-57).\n\u2013     \nAmended by Directive 2004/24/EC of the European\nParliament and of the Council of 31 March 2004 amending, as regards traditional\nherbal medicinal products, Directive 2001/83/EC on the Community code relating\nto medicinal products for human use (Official Journal L 136, 30.4.2004, p.\n85-90).\n\u2013     \nAmended by Commission Directive 2003/63/EC of 25\nJune 2003 amending Directive 2001/83/EC of the European Parliament and of the\nCouncil on the Community code relating to medicinal products for human use\n(Official Journal L 159, 27.6.2003, p. 46-94)\n\u2013     \nAmended by Directive 2002/98/EC of the European\nParliament and of the Council of 27 January 2003 setting standards of quality\nand safety for the collection, testing, processing, storage and distribution of\nhuman blood and blood components and amending Directive 2001/83/EC (Official\nJournal L 33, 8.2.2003, p 30-40)\n2.     \nRegulation (EC) No 726/2004 of the European\nParliament and of the Council of 31 March 2004 laying down Community procedures\nfor the authorisation and supervision of medicinal products for human and\nveterinary use and establishing a European Medicines Agency \n\u2013     \nAmended by Regulation (EU) no 1027/2012 of the\nEuropean Parliament and of the Council of 25 October 2012 as regards\npharmacovigilance. (OJ L 316, 14.11.2012, p. 38-40)\n\u2013     \nAmended by Regulation (EU) No 1235/2010 of the\nEuropean Parliament and of the Council of 15 December 2010 amending, as regards\npharmacovigilance of medicinal products for human use, Regulation (EC) No\n726/2004 laying down Community procedures for the authorisation and supervision\nof medicinal products for human and veterinary use and establishing a European\nMedicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy\nmedicinal products Text with EEA relevance (OJ L 348, 31.12.2010, p. 1\u201316)\n\u2013     \nAmended by Regulation (EC) No 470/2009 of the\nEuropean Parliament and of the Council of 6 May 2009 laying down Community\nprocedures for the establishment of residue limits of pharmacologically active\nsubstances in foodstuffs of animal origin, repealing Council Regulation (EEC)\nNo 2377/90 and amending Directive 2001/82/EC of the European Parliament and of\nthe Council and Regulation (EC) No 726/2004 of the European Parliament and of\nthe Council (Official Journal L 152, 16.6.2009 p. 11 - 22).\n\u2013     \nAmended by Regulation (EC) No 219/2009 of the\nEuropean Parliament and of the Council of 11 March 2009 adapting a number of\ninstruments subject to the procedure referred to in Article 251 of the Treaty\nto Council Decision 1999/468/EC with regard to the regulatory procedure with\nscrutiny Adaptation to the regulatory procedure with scrutiny - Part Two\n(Official Journal L 87, 231.3.2009, p. 109 - 154, especially p. 116 - 118,\nAnnex 2.9, where Regulation (EC) No 726/2004 is adapted).\n\u2013      Amended by Regulation (EC) No 1394/2007 of the European Parliament\nand of the Council of 13 November 2007 on advanced therapy medicinal products\nand amending Directive 2001/83/EC and Regulation (EC) No 726/2004. ( Official Journal L 324 10.12.2007,\np. 121-137)\n\u2013     \nAmended by Regulation (EC) No 1901/2006 of the\nEuropean Parliament and of the Council of 12 December 2006 on medicinal\nproducts for paediatric use and amending Regulation (EEC) No 1768/92, Directive\n2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. (Official\nJournal L 378, 27.12.2006, p. 1\u201319)\n3.     \nDirective 2001/82/EC of the European Parliament\nand of the Council of 6 November 2001 on the Community code relating to\nveterinary medicinal products \n\u2013     \nAmended by Regulation (EC) No 596/2009\nof the European Parliament and of the Council of 18 June 2009 adapting a\nnumber of instruments subject to the procedure referred to in Article 251 of\nthe Treaty to Council Decision 1999/468/EC with regard to the regulatory\nprocedure with scrutiny \u2014 Adaptation to the regulatory procedure with scrutiny\n\u2014 Part Four (Official Journal L 188, 18.7.2009, p. 14-92)\n\u2013     \nAmended by Directive 2009/53/EC of the\nEuropean Parliament and of the Council of 18 June 2009 amending Directive\n2001/82/EC and Directive 2001/83/EC, as regards variations to the terms of\nmarketing authorisations for medicinal products (Official Journal L 168,\n30.6.2009, p. 33-34)\n\u2013     \nAmended by Regulation (EC) No 470/2009 of\nthe European Parliament and of the Council of 6 May 2009 laying down Community\nprocedures for the establishment of residue limits of pharmacologically active\nsubstances in foodstuffs of animal origin, repealing Council Regulation (EEC)\nNo 2377/90 and amending Directive 2001/82/EC of the European Parliament and of\nthe Council and Regulation (EC) No 726/2004 of the European Parliament and of\nthe Council ( Official Journal L 152, 16.6.2009, p. 11-22)\n\u2013     \nAmended by Commission Directive 2009/9/EC\nof 10 February 2009 amending Directive 2001/82/EC of the European Parliament\nand of the Council on the Community code relating to medicinal products for\nveterinary use (Official Journal L 44, 14.2.2009, p.10-61)\n\u2013     \nAmended by Directive 2004/28/EC of the\nEuropean Parliament and of the Council of 31 March 2004 amending Directive\n2001/82/EC on the Community code relating to veterinary medicinal products (Official\nJournal L 136, 30.4.2004, p. 58-84)\n4.     \nCouncil Regulation (EC) No 297/95 of 10 February\n1995 on fees payable to the European Agency for the Evaluation of Medicinal\nProducts\n\u2013     \nAmended by Council Regulation (EC) No\n2743/98 of 14 December 1998 \n\u2013     \nAmended by Commission Regulation (EC) No\n494/2003 of 18 March 2003 \n\u2013     \nAmended by Council Regulation (EC) No\n1905/2005 of 14 November 2005 \n\u2013     \nAmended by Commission Regulation (EC) No\n312/2008 of 3 April 2008 \n\u2013     \nAmended by Commission Regulation (EC) No\n249/2009 of 23 March 2009 \n\u2013     \nAmended by Commission Regulation (EU) No\n261/2010 of 25 March 2010 \n\u2013     \nAmended by Commission Regulation (EU) No\n301/2011 of 28 March 2011 \n\u2013     \nAmended by Commission Regulation (EU)\nNo 273/2012 of 27 March 2012\n5.     \nRegulation (EC) No 470/2009 of the European Parliament\nand of the Council of 6 May 2009 laying down Community procedures for the\nestablishment of residue limits of pharmacologically active substances in\nfoodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and\namending Directive 2001/82/EC of the European Parliament and of the Council and\nRegulation (EC) No 726/2004 of the European Parliament and of the Council\n(Official Journal L 152, 16/6/2009 p. 11 - 22). \n6.     \nCommission Regulation (EC) No 668/2009 of 24\nJuly 2009 implementing Regulation (EC) No 1394/2007 of the European Parliament\nand of the Council with regard to the evaluation and certification of quality\nand non-clinical data relating to advanced therapy medicinal products developed\nby micro, small and medium-sized enterprises (Official Journal L 194, 25/7/2009\np. 7 - 10).\n7.     \nCommission Regulation (EU) N\u00b0 37/2010 of 22\nDecember 2009 on pharmacologically active substances and their classification\nregarding maximum residue limits in foodstuffs of animal origin\n\u2013     \nAmended by Commission Regulation (EU) No\n758/2010 of 24 August 2010 \n\u2013     \nAmended by Commission Regulation (EU) No\n759/2010 of 24 August 2010 \n\u2013     \nAmended by Commission Regulation (EU) No\n761/2010 of 25 August 2010 \n\u2013     \nAmended by Commission Regulation (EU) No\n890/2010 of 8 October 2010 \n\u2013     \nAmended by Commission Regulation (EU) No\n914/2010 of 12 October 2010 \n\u2013     \nAmended by Commission Regulation (EU) No\n362/2011 of 13 April 2011 \n\u2013     \nAmended by Commission Regulation (EU) No\n363/2011 of 13 April 2011 \n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 84/2012 of 1 February 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 85/2012 of 1 February 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 86/2012 of 1 February 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 107/2012 of 8 February 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 122/2012 of 13 February 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 123/2012 of 13 February 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 201/2012 of 8 March 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 202/2012 of 8 March 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 221/2012 of 14 March 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 222/2012 of 14 March 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 436/2012 of 23 May 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 466/2012 of 1 June 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 1161/2012 of 7 December 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 1186/2012 of 11 December 2012\n\u2013     \nAmended by Commission Implementing Regulation\n(EU) No 1191/2012 of 12 December 2012\n8.     \nCommission Regulation (EU) No 488/2012 of 8 June\n2012 amending Regulation (EC) No 658/2007 concerning financial penalties for\ninfringement of certain obligations in connection with marketing authorisations\ngranted under Regulation (EC) No 726/2004 of the European Parliament and of the\nCouncil (OJ L 150, 9.6.2012, p. 68\u201370)\n9.     \nCommission Regulation (EC) No 1234/2008 of 24\nNovember 2008 concerning the examination of variations to the terms of\nmarketing authorisations for medicinal products for human use and veterinary\nmedicinal products\n\u2013     \nAmended by Commission Regulation (EU) No\n712/2012 of 3 August 2012 amending Regulation (EC) No 1234/2008 concerning the\nexamination of variations to the terms of marketing authorisations for\nmedicinal products for human use and veterinary medicinal products (Official\nJournal L 209, 4.8.2012, p. 4 - 14).\n10. \nCommission Implementing Regulation (EU)\nNo 198/2013 of 7 March 2013 on the selection of a symbol for the\npurpose of identifying medicinal products for human use that are subject to\nadditional monitoring (Official Journal L\n65, 8/3/2013, p. 17\u201318)\n11. \nDirective 2010/63/EU of the European Parliament\nand of the Council of 22 September 2010 on the protection of animals used\nfor scientific purposes (Official Journal, L 276, 20.10.2010, p. 33\u201379)\n12. \nRegulation (EC) No 469/2009 of the European\nParliament and of the Council of 6 May 2009 concerning the supplementary\nprotection certificate for medicinal products(Official Journal L 152,\n16.6.2009, p. 1\u201310)\n13. \nDirective 2009/35/EC of the European Parliament\nand of the Council of 23 April 2009 on the colouring matters which may be added\nto medicinal products(Official Journal L 109, 30.4.2009, p. 10\u201313)\n14. \nRegulation (EC) No 1394/2007 of the European\nParliament and of the Council of 13 November 2007 on advanced therapy medicinal\nproducts and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Official\nJournal L 324, 10.12.2007, p. 121\u2013137)\n\u2013     \nAmended by Regulation (EU) No 1235/2010 of the\nEuropean Parliament and of the Council of 15 December\n2010\n15. \nCommission Regulation (EC) No 658/2007 of\n14 June 2007 concerning financial penalties for infringement of certain\nobligations in connection with marketing authorisations granted under\nRegulation (EC) No 726/2004 of the European Parliament and of the Council\n(Official Journal L 155, 15.6.2007, p. 10\u201319)\n16. \nRegulation (EC) No 1901/2006 of the European\nParliament and of the Council of 12 December 2006 on medicinal products for\npaediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC,\nDirective 2001/83/EC and Regulation (EC) No 726/2004 (Official Journal L 378,\n27.12.2006, p. 1\u201319)\n\u2013     \nAmended by Regulation (EC) No 469/2009 of the\nEuropean Parliament and of the Council of 6 May 2009\n\u2013     \nAmended by Regulation (EC) No 1902/2006 of the\nEuropean Parliament and of the Council of 20 December 2006\n17. \nCommission Regulation (EC) No 507/2006 of 29\nMarch 2006 on the conditional marketing authorisation for medicinal products\nfor human use falling within the scope of Regulation (EC) No 726/2004 of the\nEuropean Parliament and of the Council (Official Journal L 92, 30.3.2006, p.\n6\u20139)\n18. \nCommission Regulation (EC) No 2049/2005 of\n15 December 2005 laying down, pursuant to Regulation (EC) No 726/2004 of\nthe European Parliament and of the Council, rules regarding the payment of fees\nto, and the receipt of administrative assistance from, the European Medicines\nAgency by micro, small and medium-sized enterprises (Official Journal L 329,\n16.12.2005, p. 4\u20137)\n19. \nCommission Directive 2005/28/EC of 8 April 2005\nlaying down principles and detailed guidelines for good clinical practice as\nregards investigational medicinal products for human use, as well as the requirements\nfor authorisation of the manufacturing or importation of such products(Official\nJournal L 91, 9.4.2005, p. 13\u201319)\n20. \nDirective 2004/10/EC of the European Parliament\nand of the Council of 11 February 2004 on the harmonisation of laws,\nregulations and administrative provisions relating to the application of the\nprinciples of good laboratory practice and the verification of their\napplications for tests on chemical substances ( Official Journal L 50,\n20.2.2004, p. 44\u201359)\n\u2013     \nAmended by Regulation (EC) No 219/2009 of the\nEuropean Parliament and of the Council of 11 March 2009\n21. \nDirective 2004/9/EC of the European Parliament\nand of the Council of 11 February 2004 on the inspection and verification of\ngood laboratory practice (GLP) (Official Journal L 50, 20.2.2004, p. 28\u201343)\n\u2013     \nAmended by Regulation (EC) No 219/2009 of the\nEuropean Parliament and of the Council of 11 March 2009\n22. \nCommission Directive 2003/94/EC of 8 October\n2003 laying down the principles and guidelines of good manufacturing practice\nin respect of medicinal products for human use and investigational medicinal\nproducts for human use (Official Journal L 262, 14.10.2003, p. 22\u201326)\n23. \nCouncil Regulation (EC) No 953/2003 of 26 May\n2003 to avoid trade diversion into the European Union of certain key medicines\n( Official Journal L 135, 3.6.2003, p. 5\u201311)\n\u2013     \nAmended by Commission Regulation (EC) No\n1876/2004 of 28 October 2004 \n\u2013     \nAmended by Commission Regulation (EC) No\n1662/2005 of 11 October 2005\n24. \nRegulation (EC) No 141/2000 of the European\nParliament and of the Council of 16 December 1999 on orphan medicinal products\n(Official Journal L 18, 22.1.2000)\n\u2013     \nAmended by Regulation (EC) No 596/2009 of the\nEuropean Parliament and of the Council of 18 June 2009\n25.  Directive\n91/412/CEE de la Commission, du 23 juillet 1991, \u00e9tablissant les principes et\nlignes directrices de bonnes pratiques de fabrication pour les m\u00e9dicaments\nv\u00e9t\u00e9rinaires (Official Journal L 228 du 17.8.1991, p. 70\u201373)\n26.  Directive\n89/105/CEE du Conseil du 21 d\u00e9cembre 1988 concernant la transparence des\nmesures r\u00e9gissant la fixation des prix des m\u00e9dicaments \u00e0 usage humain et leur\ninclusion dans le champ d'application des syst\u00e8mes d'assurance-maladie (Official\nJournal L 40 of 11.02.1989, p. 8\u201311)\nII. COSMETICS\nACTS REFERRED TO \n1.     \nCouncil Directive 76/768/EEC of 27 July 1976 on\nthe approximation of the laws of the Member States relating to cosmetic\nproducts (OJ L 262, 27.9.1976, p. 169), as amended by:\n\u2013     \nCouncil Directive 79/661/EEC of 24 July 1979 (OJ\nL 192, 31.7.1979, p.35)\n\u2013     \nCommission Directive 82/147/EEC of 11 February\n1982 (OJ L 63, 6.3.1982, p. 26)\n\u2013     \nCouncil Directive 82/368/EEC of 17 May 1982 (OJ\nL 167, 15.6.1982, p. 1)\n\u2013     \nCommission Directive 83/191/EEC of 30 March 1983\n(OJ L 109, 26.4.1983, p.25)\n\u2013     \nCommission Directive 83/341/EEC of 29 June 1983\n(OJ L 188, 13.7.1983, p. 15)\n\u2013     \nCommission Directive 83/496/EEC of 22 September\n1983 (OJ L 275, 8.10.1983, p. 20)\n\u2013     \nCouncil Directive 83/574/EEC of 26 October 1983\n(OJ L 332, 28.11.1983, p. 38)\n\u2013     \nCommission Directive 84/415/EEC of 18 July 1984\n(OJ L 228, 25.8.1984, p. 31)\n\u2013     \nCommission Directive 85/391/EEC of 16 July 1985\n(OJ L 224, 22.8.1985, p.40)\n\u2013     \nCommission Directive 86/179/EEC of 28 February\n1986 (OJ L 138, 24.5.1986, p. 40)\n\u2013     \nCommission Directive 86/199/EEC of 26 March 1986\n(OJ L 149, 3.6.1986, p. 38)\n\u2013     \nCommission Directive 87/137/EEC of 2 February 1987\n(OJ L 56, 26.2.1987, p. 20)\n\u2013     \nCommission Directive 88/233/EEC of 2 March 1988\n(OJ L 105, 26.4.1988, p.11)\n\u2013     \nCouncil Directive 88/667/EEC of 21 December 1988\n(OJ L 382, 31.12.1988, p.46) \n\u2013     \nCommission Directive 89/174/EEC of 21 February\n1989 (OJ L 64, 8.3.1989, p. 10)\n\u2013     \nCouncil Directive 89/679/EEC of 21 December 1989\n(OJ L 398, 30.12.1989, p.25)\n\u2013     \nCommission Directive 90/121/EEC of 20 February\n1990 (OJ L 71, 17.3.1990, p. 40)\n\u2013     \nCommission Directive 91/184/EEC of 12 March 1991\n(OJ L 91, 12.4.1991, p. 59)\n\u2013     \nCommission Directive 92/8/EEC of 18 February\n1992 (OJ L 70, 17.3.1992, p. 23)\n\u2013     \nCommission Directive 92/86/EEC of 21 October\n1992 (OJ L 325, 11.11.1992, p. 18)\n\u2013     \nCouncil Directive 93/35/EEC of 14 June 1993 (OJ\nL 151, 23.6.1993, p. 32)\n\u2013     \nCommission Directive 93/47/EEC of 22 June 1993\n(OJ L 203, 13.8.1993, p. 24)\n\u2013     \nCommission Directive 94/32/EC of 29 June 1994\n(OJ L 181, 15.7.1994, p. 31)\n\u2013     \nCommission Directive 95/34/EC of 10 July 1995\n(OJ L 167, 18.7.1995, p. 19)\n\u2013     \nCommission Directive 96/41/EC of 25 June 1996\n(OJ L 1988.8.1996, p. 36)\n\u2013     \nCommission Directive 97/1/EC of 10 January 1997\n(OJ L 16, 18.1.1997, p. 85)\n\u2013     \nCommission Directive 97/18/EC of 17 April l997\n(OJ L 114, 1.5.1997, p. 43)\n\u2013     \nCommission Directive 97/45/EC of 14 July 1997\n(OJ L 196, 24.7.1997, p. 77)\n\u2013     \nCommission Directive 98/16/EC of 5 March 1998\n(OJ L 77, 14.3.1998, p. 44)\n\u2013     \nCommission Directive 98/62/EC of 3 September\n1998 (OJ L 253, 15.9.1998, p. 20)\n\u2013     \nCommission Directive 2000/6/EC of 29 February\n2000 (OJ L 56, 1.3.2000, p. 42)\n\u2013     \nCommission Directive 2000/11/EC of 10 March 2000\n(OJ L 65, 14.3.2000, p. 22)\n\u2013     \nCommission Directive 2000/41/EC of 19 June 2000\n(OJ L 145, 20.6.2000, p. 25)\n\u2013     \nCommission Directive 2002/34/EC of 15 April 2002\n(OJ L 102, 18.4.2002, p. 19)\n\u2013     \nCommission Directive 2003/1/EC of 6 January 2003\n(L 5, 10.1.2003, p. 14)\n\u2013     \nCommission Directive 2003/16/EC of 19 February\n2003 (OJ L 46, 20.2.2003, p. 24)\n\u2013     \nDirective 2003/15/EC of the European Parliament\nand of the Council of 27 February 2003 (OJ L 66, 11.3.2003, p. 26)\n\u2013     \nCommission Directive 2003/80/EC of 5 September\n2003 (OJ L 224, 6.9.2003, p. 27)\n\u2013     \nCommission Directive 2003/83/EC of 24 September\n2003 (OJ L 238, 25.9.2003, p. 23)\n\u2013     \nCommission Directive 2004/87/EC of 7 September\n2004 (OJ L 287, 8.9.2004, p. 4)\n\u2013     \nCommission Directive 2004/88/EC of 7 September\n2004 (OJ L 287, 8.9.2004, p. 5)\n\u2013     \nCommission Directive 2004/94/EC of 15 September\n2004 (OJ L 294, 17.9.2004, p. 28)\n\u2013     \nCommission Directive 2004/93/EC of 21 September\n2004 (OJ L 300, 25.9.2004, p. 13)\n\u2013     \nCommission Directive 2005/9/EC of 28 January\n2005 (OJ L 27, 29.1.2005, p. 46)\n\u2013     \nCommission Directive 2005/42/EC of 20 June 2005\n(OJ L 158, 21.6.2005, p. 17)\n\u2013     \nCommission Directive 2005/52/EC of 9 September\n2005 (OJ L 234, 10.9.2005, p. 9)\n\u2013     \nCommission Directive 2005/80/EC of 21 November\n2005 (OJ L 303, 22.11.2005, p. 32)\n\u2013     \nCommission Directive 2006/65/EC of 19 July 2006\n(OJ L 198, 20.7.2006, p. 11)\n\u2013     \nCommission Directive 2006/78/EC of 29 September\n2006 (OJ L 271, 30.9.2006, p. 56)\n\u2013     \nCommission Directive 2007/1/EC of 29 January\n2007 (OJ L 25, 1.2.2007, p. 9)\n\u2013     \nCommission Directive 2007/17/EC of 22 March 2007\n(OJ L 82, 23.3.2007, p. 27)\n\u2013     \nCommission Directive 2007/22/EC of 17 April 2007\n(OJ L 101, 18.4.2007, p. 11)\n\u2013     \nCommission Directive 2007/53/EC of 29 August\n2007 (OJ L 226, 30.8.2007, p. 19)\n\u2013     \nCommission Directive 2007/54/EC of 29 August\n2007 (OJ L 226, 30.8.2007, p. 21)\n\u2013     \nCommission Directive 2007/67/EC of 22 November\n2007 (OJ L 305, 23.11.2007, p. 22)\n\u2013     \nCommission Directive 2008/14/EC of 15 February\n2008 (OJ L 42, 16.2.2008, p. 43)\n\u2013     \nCommission Directive 2008/42/EC of 3 April 2008\n(OJ L 93, 4.4.2008, p. 13)\n\u2013     \nCommission Directive 2008/88/EC of 23 September\n2008 (OJ L 256, 24.9.2008, p. 12)\n\u2013     \nCommission Directive 2008/123/EC of 18 December\n2008 (OJ L 340, 19.12.2008, p. 71)\n\u2013     \nDirective 2008/112/EC of the European Parliament\nand of the Council of 16 December 2008 (L 345, 23.12.2008, p. 68)\n\u2013     \nCommission Directive 2009/6/EC of 4 February\n2009 (L 36, 5.2.2009, p. 15)\n\u2013     \nCommission Directive 2009/36/EC of 16 April 2009\n(OJ L 98, 17.4.2009, p. 31)\n\u2013     \nCommission Directive 2009/129/EC of 9 October\n2009 (L 267, 10.10.2009, p. 18)\n\u2013     \nCommission Directive 2009/130/EC of 12 October\n2009 (L 268, 13.10.2009, p. 5)\n\u2013     \nCommission Directive 2009/134/EC of 28 October\n2009 (L 282, 29.10.2009, p. 15)\n\u2013     \nCommission Directive 2009/159/EU of 16 December\n2009 (OJ L 336, 18.12.2009, p. 29)\n\u2013     \nRegulation (EC) No 1223/2009 of the European\nParliament and of the Council of 30 November 2009 (OJ L 342, 22.12.2009, p. 59)\n\u2013     \nCommission Directive 2009/164/EU of 22 December\n2009 (OJ L 344, 23.12.2009, p. 41)\n\u2013     \nCommission Directive 2010/3/EU of 1 February\n2010 (OJ L 29, 2.2.2010, p. 5)\n\u2013     \nCommission Directive 2010/4/EU of 8 February\n2010 (OJ L 36, 9.2.2010, p. 21)\n\u2013     \nCommission Directive 2011/59/EU of 13 May 2011\n(OJ L 125, 14.5.2011, p. 17)\n\u2013     \nCouncil Directive 2011/84/EU of 20 September\n2011 (OJ L 283, 29.10.2011, p. 36)\n\u2013     \nCommission Implementing Directive 2012/21/EU of\n2 August 2012 (OJ L 208, 3.8.2012, p. 8) \nDirective 76/768/EEC will be repealed\nwith effect from 11 July 2013 and will be replaced by:\n2.     \nRegulation (EC) No 1223/2009 of the European\nParliament and of the Council of 30 November 2009 on cosmetic products. (OJ L\n342, 22.12.2009, p.59)\n3.     \nCommission Directive 80/1335/EEC of 22 December\n1980 on the approximation of the laws of the Member States relating to methods\nof analysis necessary for checking the composition of cosmetic products (OJ L\n383, 31.12.1980, p. 27), as amended by:\n\u2013     \nCommission Directive 87/143/EEC of 10 February\n1987 (OJ L 57, 27.2.1987, p. 56).\n4.     \nCommission Directive 82/434/EEC of 14 May 1982\non the approximation of the laws of the Member States relating to methods of\nanalysis necessary for checking the composition of cosmetic products (OJ L 185,\n30.6.1982, p. 1), as amended by:\n\u2013     \nCommission Directive 90/207/EEC of 4 April 1990\n(OJ L 108, 28.4.1990, p. 92).\n5.     \nCommission Directive 83/514/EEC of 27 September\n1983 on the approximation of the laws of the Member States relating to methods\nof analysis necessary for checking the composition of cosmetic products (OJ L\n291, 24.10.1983, p. 9).\n6.     \nCommission Directive 85/490/EEC of 11 October\n1985 on the approximation of laws of the Member States relating to methods of\nanalysis necessary for checking the composition of cosmetic products (OJ L 295,\n7.11.1985, p. 30).\n7.     \nCommission Directive 93/73/EEC of 9 September\n1993 on the methods of analysis necessary for checking the composition of\ncosmetic products (OJ L 231, 14.9.1993, p. 34).\n8.     \nCommission Directive 95/17/EC of 19 June 1995\nlaying down detailed rules for the application of Council Directive 76/768/EEC\nas regards the non-inclusion of one or more ingredients on the list used for\nthe labelling of cosmetic products (OJ L 140, 23.6.1995, p. 26). \n\u2013     \nAmended by Commission Directive 2006/81/EC of 23\nOctober 2006 (OJ L 362, 20.12.2006, p. 92)\n\u2013     \nAmended by Act concerning the conditions of\naccession of the Czech Republic, the Republic of Estonia, the Republic of Cyprus,\nthe Republic of Latvia, the Republic of Lithuania, the Republic of Hungary, the\nRepublic of Malta, the Republic of Poland, the Republic of Slovenia and the\nSlovak Republic and the adjustments to the Treaties on which the European Union\nis founded (OJ L 236, 23.9.2003, p.33)\n9.     \nThis directive will be repealed with effect from\n11 July 2013.\n10. \nCommission Directive 95/32/EC of 7 July 1995\nrelating to methods of analysis necessary for checking the composition of\ncosmetic products (OJ L 178, 28.7.1995, p. 20).\n11. \nCommission Directive 96/45/EC of 2 July 1996\nrelating to methods of analysis necessary for checking the composition of\ncosmetic products (OJ L 213, 22.8.1996, p. 8).\n12. \nCommission Decision of 8 May 1996 establishing\nan inventory and a common nomenclature of ingredients employed in cosmetic\nproducts ( OJ L 132, 1.6.1996, p. 1\u2013\u2013)\n\u2013     \nAmended by Commission Decision 2006/257/EC, (OJ\nL 97, 5.4.2006, p. 1)\nIII. MEDICAL DEVICES\nACTS REFERRED TO\n1.     \nCouncil Directive 90/385/EEC of 20 June 1990 on\nthe approximation of the laws of the Member States relating to active\nimplantable medical devices (OJ L 189, 20.7.1990, p. 17), as amended by:\n\u2013     \nAmended by Council Directive 93/42/EEC of 14\nJune 1993 (OJ L 169, 12.7.1993, p. 1).\n\u2013     \nAmended by Council Directive 93/68/EEC of 22\nJuly 1993 (OJ L 220, 30.8.1993, p.1).\n\u2013     \nAmended by Regulation (EC) No 1882/2003 of the\nEuropean Parliament and of the Council of 29 September 2003 (OJ L 284,\n31.10.2003, p. 1).\n\u2013     \nAmended by Directive 2007/47/EC of the European\nParliament and of the Council of 5 September 2007 (OJ L 247, 21.09.2007, p.\n21). \n2.     \nCouncil Directive 93/42/EEC of 14 June 1993\nconcerning medical devices (OJ L 169, 12.7.1993, p. 1).\n\u2013     \nAmended by Directive 98/79/EC of the European\nParliament and of the Council of 27 October 1998 on in vitro diagnostic medical\ndevices (OJ L 331, 7.12.1998, p. 1).\n\u2013     \nAmended by Directive 2000/70/EC of the European\nParliament and of the Council of 16 November 2000 amending Council Directive\n93/42/EEC as regards medical devices incorporating stable derivates of human\nblood or human plasma (OJ L 313, 13.12.2000, p. 22).\n\u2013     \nAmended by Directive 2001/104/EC of the European\nParliament and of the Council of 7 December 2001 amending Council Directive\n93/42/EEC concerning medical devices (OJ L 6, 10.1.2002, p. 50).\n\u2013     \nAmended by Regulation (EC) No 1882/2003 of the\nEuropean Parliament and of the Council of 29 September 2003 (OJ L 284,\n31.10.2003, p.1).\n\u2013     \nAmended by Regulation (EC) No 1882/2003 of the\nEuropean Parliament and of the Council of 29 September 2003 (OJ L 284,\n31.10.2003, p.1).\n\u2013     \nAmended by Directive 2007/47/EC of the European\nParliament and of the Council of 5 September 2007 (OJ L 247, 21.9.2007, p.21).\n3.     \nDirective 98/79/EC of the European Parliament\nand of the Council of 27 October 1998 on in vitro diagnostic medical devices\n(OJ L 331, 7.12.1998, p. 1). \n\u2013     \nAmended by Regulation (EC) No 1882/2003 of the\nEuropean Parliament and of the Council of 29 September 2003 (OJ L 284,\n31.10.2003, p. 1).\n\u2013     \nAmended by Regulation (EC) No 596/2009 of the\nEuropean Parliament and of the Council of 18 June 2009 (OJ L 188, 18.07.2009,\np.14).\n\u2013     \nAmended by Commission Directive 2011/100/EU of\n20 December 2011 (OJ L 341, 22.12.2011, p. 50).\n4.     \nCommission Decision 2002/364/EC of 7 May 2002 on\ncommon technical specifications for in vitro diagnostic medical devices (OJ L\n131, 16.5.2002, p.17)\n\u2013     \nAmended by Commission Decision 2009/108/EC of 3\nFebruary 2009 (OJ L 39, 10.02.2009, p.34).\n\u2013     \nAmended by Commission Decision 2009/886/EC of 27\nNovember 2009 (OJ L 318, 4.12.2009, p.25). \n\u2013     \nAmended by Commission Decision 2011/869/EU of 20\nDecember 2011 (OJ L 341, 22.12.2011, p.63). \n5.     \nCommission Directive 2003/12/EC of 3 February\n2003 on the reclassification of breast implants in the framework of Directive\n93/42/EEC concerning medical devices (OJ L 28, 4.2.2003, p.43).\n6.     \nCommission Directive 2003/32/EC of 23 April 2003\nintroducing detailed specifications as regards the requirements laid down in\nCouncil Directive 93/42/EEC with respect to medical devices manufactured\nutilising tissues of animal origin (OJ L 105, 26.4.2003, p.18).\n7.     \nCommission Directive 2005/50/EC of 11 August\n2005 on the reclassification of hip, knee and shoulder joint replacements in\nthe framework of Council Directive 93/42/EEC concerning medical devices (OJ L\n210, 12.08.2005, p.41).\n8.     \nCommission Decision 2010/227/EU of 19 April 2010\non the European Databank on Medical Devices (Eudamed) (OJ L102, 23.04.2010,\np.45). \n9.     \nCommission Regulation (EU) No 207/2012 of 9\nMarch 2012 on electronic instructions for use of medical devices (OJ L72,\n10.03.2012, p.28).\n10. \nCommission Regulation (EU) No 722/2012 of 8 August\n2012 concerning particular requirements as regards the requirements laid down\nin Council Directives 90/385/EEC and 93/42/EEC with respect to active\nimplantable medical devices and medical devices manufactured utilising tissues\nof animal origin (OJ 212, 9.08.2012, p.3). \n[1]\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OJ L 332, 19.12.2003, pp.42-43.\n[2]\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OJ L 332, 19.12.2003, pp.42-43.\n[3]\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OJ L 332, 19.12.2003, pp.42-43.\n[4]\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OJ L 332, 19.12.2003, pp.42-43.\n\n\n\n\nTop  \n  "